AstraZeneca says blood thinner met key study goals - BusinessWeek

[INCIID News Feed]

TopNews New Zealand
<img alt="" height="1" width="1" />
AstraZeneca says blood thinner met key study goals
BusinessWeek
AstraZeneca PLC&#39;s potential blood thinner drug met key goals in a genetic substudy of heart condition patients. Ticagrelor is already under Food and Drug Administration review and would compete with Bristol-Myers Squibb and Sanofi-Aventis&#39; Plavix. ...
Value of Plavix Genetic Test to Avoid Heart Risk QuestionedAboutLawsuits.com
Will gene-testing be a blood-thinner battleground?FiercePharma
Plavix Rival Gains From StudiesWall Street Journal
Reuters -TopNews New Zealand -Medical News Today
all 44 news articles &raquo;


More...